Copyright Reports & Markets. All rights reserved.

Global Antimicrobial Formulations Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Antimicrobial Formulations Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Triclosan
    • 1.3.3 Triclocarban
    • 1.3.4 Parabens
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Antimicrobial Formulations Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Antibacterial Drug
    • 1.4.3 Antifungal Drug
    • 1.4.4 Antiviral Agent
    • 1.4.5 Antiparasitic drug
    • 1.4.6 Others
  • 1.5 Global Antimicrobial Formulations Market Size & Forecast
    • 1.5.1 Global Antimicrobial Formulations Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Antimicrobial Formulations Sales Quantity (2021-2032)
    • 1.5.3 Global Antimicrobial Formulations Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Antimicrobial Formulations Product and Services
    • 2.1.4 Pfizer Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 GlaxoSmithKline
    • 2.2.1 GlaxoSmithKline Details
    • 2.2.2 GlaxoSmithKline Major Business
    • 2.2.3 GlaxoSmithKline Antimicrobial Formulations Product and Services
    • 2.2.4 GlaxoSmithKline Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GlaxoSmithKline Recent Developments/Updates
  • 2.3 Finecure Pharmaceuticals Limited
    • 2.3.1 Finecure Pharmaceuticals Limited Details
    • 2.3.2 Finecure Pharmaceuticals Limited Major Business
    • 2.3.3 Finecure Pharmaceuticals Limited Antimicrobial Formulations Product and Services
    • 2.3.4 Finecure Pharmaceuticals Limited Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Finecure Pharmaceuticals Limited Recent Developments/Updates
  • 2.4 Centrient Pharmaceuticals
    • 2.4.1 Centrient Pharmaceuticals Details
    • 2.4.2 Centrient Pharmaceuticals Major Business
    • 2.4.3 Centrient Pharmaceuticals Antimicrobial Formulations Product and Services
    • 2.4.4 Centrient Pharmaceuticals Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Centrient Pharmaceuticals Recent Developments/Updates
  • 2.5 Otsuka Pharmaceutical Factory
    • 2.5.1 Otsuka Pharmaceutical Factory Details
    • 2.5.2 Otsuka Pharmaceutical Factory Major Business
    • 2.5.3 Otsuka Pharmaceutical Factory Antimicrobial Formulations Product and Services
    • 2.5.4 Otsuka Pharmaceutical Factory Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Otsuka Pharmaceutical Factory Recent Developments/Updates
  • 2.6 Foster Corporation
    • 2.6.1 Foster Corporation Details
    • 2.6.2 Foster Corporation Major Business
    • 2.6.3 Foster Corporation Antimicrobial Formulations Product and Services
    • 2.6.4 Foster Corporation Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Foster Corporation Recent Developments/Updates
  • 2.7 Hindustan Antibiotics Limited
    • 2.7.1 Hindustan Antibiotics Limited Details
    • 2.7.2 Hindustan Antibiotics Limited Major Business
    • 2.7.3 Hindustan Antibiotics Limited Antimicrobial Formulations Product and Services
    • 2.7.4 Hindustan Antibiotics Limited Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hindustan Antibiotics Limited Recent Developments/Updates
  • 2.8 Sandoz International GmbH
    • 2.8.1 Sandoz International GmbH Details
    • 2.8.2 Sandoz International GmbH Major Business
    • 2.8.3 Sandoz International GmbH Antimicrobial Formulations Product and Services
    • 2.8.4 Sandoz International GmbH Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sandoz International GmbH Recent Developments/Updates
  • 2.9 Stepan Company
    • 2.9.1 Stepan Company Details
    • 2.9.2 Stepan Company Major Business
    • 2.9.3 Stepan Company Antimicrobial Formulations Product and Services
    • 2.9.4 Stepan Company Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Stepan Company Recent Developments/Updates
  • 2.10 Ciron Drugs
    • 2.10.1 Ciron Drugs Details
    • 2.10.2 Ciron Drugs Major Business
    • 2.10.3 Ciron Drugs Antimicrobial Formulations Product and Services
    • 2.10.4 Ciron Drugs Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Ciron Drugs Recent Developments/Updates
  • 2.11 API Co. Ltd
    • 2.11.1 API Co. Ltd Details
    • 2.11.2 API Co. Ltd Major Business
    • 2.11.3 API Co. Ltd Antimicrobial Formulations Product and Services
    • 2.11.4 API Co. Ltd Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 API Co. Ltd Recent Developments/Updates
  • 2.12 Nabriva Therapeutics
    • 2.12.1 Nabriva Therapeutics Details
    • 2.12.2 Nabriva Therapeutics Major Business
    • 2.12.3 Nabriva Therapeutics Antimicrobial Formulations Product and Services
    • 2.12.4 Nabriva Therapeutics Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Nabriva Therapeutics Recent Developments/Updates
  • 2.13 Lonza
    • 2.13.1 Lonza Details
    • 2.13.2 Lonza Major Business
    • 2.13.3 Lonza Antimicrobial Formulations Product and Services
    • 2.13.4 Lonza Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Lonza Recent Developments/Updates
  • 2.14 Microban
    • 2.14.1 Microban Details
    • 2.14.2 Microban Major Business
    • 2.14.3 Microban Antimicrobial Formulations Product and Services
    • 2.14.4 Microban Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Microban Recent Developments/Updates
  • 2.15 Hanmi Pharm.Co.,Ltd.
    • 2.15.1 Hanmi Pharm.Co.,Ltd. Details
    • 2.15.2 Hanmi Pharm.Co.,Ltd. Major Business
    • 2.15.3 Hanmi Pharm.Co.,Ltd. Antimicrobial Formulations Product and Services
    • 2.15.4 Hanmi Pharm.Co.,Ltd. Antimicrobial Formulations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Hanmi Pharm.Co.,Ltd. Recent Developments/Updates

3 Competitive Environment: Antimicrobial Formulations by Manufacturer

  • 3.1 Global Antimicrobial Formulations Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Antimicrobial Formulations Revenue by Manufacturer (2021-2026)
  • 3.3 Global Antimicrobial Formulations Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Antimicrobial Formulations by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Antimicrobial Formulations Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Antimicrobial Formulations Manufacturer Market Share in 2025
  • 3.5 Antimicrobial Formulations Market: Overall Company Footprint Analysis
    • 3.5.1 Antimicrobial Formulations Market: Region Footprint
    • 3.5.2 Antimicrobial Formulations Market: Company Product Type Footprint
    • 3.5.3 Antimicrobial Formulations Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Antimicrobial Formulations Market Size by Region
    • 4.1.1 Global Antimicrobial Formulations Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Antimicrobial Formulations Consumption Value by Region (2021-2032)
    • 4.1.3 Global Antimicrobial Formulations Average Price by Region (2021-2032)
  • 4.2 North America Antimicrobial Formulations Consumption Value (2021-2032)
  • 4.3 Europe Antimicrobial Formulations Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Antimicrobial Formulations Consumption Value (2021-2032)
  • 4.5 South America Antimicrobial Formulations Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Antimicrobial Formulations Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Antimicrobial Formulations Sales Quantity by Type (2021-2032)
  • 5.2 Global Antimicrobial Formulations Consumption Value by Type (2021-2032)
  • 5.3 Global Antimicrobial Formulations Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Antimicrobial Formulations Sales Quantity by Application (2021-2032)
  • 6.2 Global Antimicrobial Formulations Consumption Value by Application (2021-2032)
  • 6.3 Global Antimicrobial Formulations Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Antimicrobial Formulations Sales Quantity by Type (2021-2032)
  • 7.2 North America Antimicrobial Formulations Sales Quantity by Application (2021-2032)
  • 7.3 North America Antimicrobial Formulations Market Size by Country
    • 7.3.1 North America Antimicrobial Formulations Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Antimicrobial Formulations Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Antimicrobial Formulations Sales Quantity by Type (2021-2032)
  • 8.2 Europe Antimicrobial Formulations Sales Quantity by Application (2021-2032)
  • 8.3 Europe Antimicrobial Formulations Market Size by Country
    • 8.3.1 Europe Antimicrobial Formulations Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Antimicrobial Formulations Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Antimicrobial Formulations Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Antimicrobial Formulations Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Antimicrobial Formulations Market Size by Region
    • 9.3.1 Asia-Pacific Antimicrobial Formulations Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Antimicrobial Formulations Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Antimicrobial Formulations Sales Quantity by Type (2021-2032)
  • 10.2 South America Antimicrobial Formulations Sales Quantity by Application (2021-2032)
  • 10.3 South America Antimicrobial Formulations Market Size by Country
    • 10.3.1 South America Antimicrobial Formulations Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Antimicrobial Formulations Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Antimicrobial Formulations Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Antimicrobial Formulations Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Antimicrobial Formulations Market Size by Country
    • 11.3.1 Middle East & Africa Antimicrobial Formulations Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Antimicrobial Formulations Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Antimicrobial Formulations Market Drivers
  • 12.2 Antimicrobial Formulations Market Restraints
  • 12.3 Antimicrobial Formulations Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Antimicrobial Formulations and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Antimicrobial Formulations
  • 13.3 Antimicrobial Formulations Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Antimicrobial Formulations Typical Distributors
  • 14.3 Antimicrobial Formulations Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Antimicrobial Formulations market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Components of an agent that kills microorganisms or stops their growth.
    This report is a detailed and comprehensive analysis for global Antimicrobial Formulations market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Antimicrobial Formulations market size and forecasts, in consumption value ($ Million), sales quantity (Kilograms), and average selling prices (US$/Kilogram), 2021-2032
    Global Antimicrobial Formulations market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilograms), and average selling prices (US$/Kilogram), 2021-2032
    Global Antimicrobial Formulations market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilograms), and average selling prices (US$/Kilogram), 2021-2032
    Global Antimicrobial Formulations market shares of main players, shipments in revenue ($ Million), sales quantity (Kilograms), and ASP (US$/Kilogram), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Antimicrobial Formulations
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Antimicrobial Formulations market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, GlaxoSmithKline, Finecure Pharmaceuticals Limited, Centrient Pharmaceuticals, Otsuka Pharmaceutical Factory, Foster Corporation, Hindustan Antibiotics Limited, Sandoz International GmbH, Stepan Company, Ciron Drugs, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Antimicrobial Formulations market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Triclosan
    Triclocarban
    Parabens
    Market segment by Application
    Antibacterial Drug
    Antifungal Drug
    Antiviral Agent
    Antiparasitic drug
    Others
    Major players covered
    Pfizer
    GlaxoSmithKline
    Finecure Pharmaceuticals Limited
    Centrient Pharmaceuticals
    Otsuka Pharmaceutical Factory
    Foster Corporation
    Hindustan Antibiotics Limited
    Sandoz International GmbH
    Stepan Company
    Ciron Drugs
    API Co. Ltd
    Nabriva Therapeutics
    Lonza
    Microban
    Hanmi Pharm.Co.,Ltd.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Antimicrobial Formulations product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Antimicrobial Formulations, with price, sales quantity, revenue, and global market share of Antimicrobial Formulations from 2021 to 2026.
    Chapter 3, the Antimicrobial Formulations competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Antimicrobial Formulations breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Antimicrobial Formulations market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Antimicrobial Formulations.
    Chapter 14 and 15, to describe Antimicrobial Formulations sales channel, distributors, customers, research findings and conclusion.

    Buy now